|Articles|July 27, 2015
Janet Freeman-Daily on Why Patients Should Attend the ASCO Meeting
Author(s)Janet Freeman-Daily
Janet Freeman-Daily on why patients should attend the annual meeting of the American Society of Clinical Oncology (ASCO).
Advertisement
We spoke with Janet Freeman-Daily, a patient with metastatic lung cancer and a CURE contributor, during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago. Here, Freeman-Daily discusses why patients should attend the meeting.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch
2
6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You
3
FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer
4
From Precision Medicine to AI: The Future of Cancer Care
5